Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 18, 2007

Novasep to Take Over PharmaChem

  • Novasep reports that it is finalizing discussions to buy PharmaChem Technologies. Customers will now benefit from Novasep’s R&D capabilities and technologies along with PharmaChem’s manufacturing capacity to produce APIs and intermediates.

    “Groupe Novasep intends to continue developing PharmaChem’s activities and to build synergies with our Synthesis and Process businesses,” remarks Roger-Marc Nicoud, president of Novasep.

    PharmaChem’s has a cGMP-compliant plant based in Freeport, Bahamas. Once the transaction is complete both companies will continue to operate under their current names and management structure.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »